litlas
Log inCreate account

Stephen E. Sallan

Active 1975–2025

120
Papers
28,560
Citations
96
h-index
119
i10-index

Citations

Citations per year for Stephen E. Sallan1968: 1 citations1977: 1 citations1978: 1 citations1979: 7 citations1980: 6 citations1981: 10 citations1982: 5 citations1983: 18 citations1984: 25 citations1985: 29 citations1986: 25 citations1987: 31 citations1988: 31 citations1989: 32 citations1990: 26 citations1991: 41 citations1992: 33 citations1993: 38 citations1994: 37 citations1995: 56 citations1996: 66 citations1997: 80 citations1998: 107 citations1999: 111 citations2000: 165 citations2001: 115 citations2002: 170 citations2003: 186 citations2004: 214 citations2005: 228 citations2006: 225 citations2007: 228 citations2008: 221 citations2009: 253 citations2010: 238 citations2011: 230 citations2012: 289 citations2013: 263 citations2014: 281 citations2015: 358 citations2016: 294 citations2017: 294 citations2018: 202 citations2019: 697 citations2020: 722 citations2021: 579 citations2022: 454 citations2023: 253 citations2024: 404 citations2025: 171 citations2026: 2 citations1969–1976: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,381 citing papers, 34.9% of this breakdownChina: 626 citing papers, 6.5% of this breakdownUnited Kingdom: 573 citing papers, 5.9% of this breakdownGermany: 538 citing papers, 5.6% of this breakdownCanada: 456 citing papers, 4.7% of this breakdownItaly: 431 citing papers, 4.4% of this breakdownNetherlands: 371 citing papers, 3.8% of this breakdownFrance: 324 citing papers, 3.3% of this breakdownAustralia: 264 citing papers, 2.7% of this breakdownJapan: 208 citing papers, 2.1% of this breakdownSpain: 191 citing papers, 2% of this breakdownSwitzerland: 175 citing papers, 1.8% of this breakdown
0%34.9%Other 22.3%

Institutions

Fields

  • Medicine64.8%
  • Biochemistry, Genetics and Molecular Biology29.6%
  • Computer Science2.1%
  • Immunology and Microbiology1.5%
  • Engineering0.4%
  • Neuroscience0.3%
  • Other1.3%

Topics

  • Acute Lymphoblastic Leukemia research9.2%
  • Childhood Cancer Survivors' Quality of Life5.5%
  • Acute Myeloid Leukemia Research5%
  • Chemotherapy-induced cardiotoxicity and mitigation4.5%
  • Chronic Myeloid Leukemia Treatments2.4%
  • Gene expression and cancer classification2.4%
  • Other71%

Coauthors

All papers

Open in search
  1. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element

    Authors: Marc R. Mansour, Brian J. Abraham, Lars Anders, Alla Berezovskaya, Alejandro Gutiérrez, Adam D. Durbin, Julia Etchin, Lee N. Lawton, Stephen E. Sallan, Lewis B. Silverman, Mignon L. Loh, Stephen P. Hunger, Takaomi Sanda, Richard A. Young, A. Thomas Look - Science 2014 cited by 829

  2. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia

    Authors: Scott A. Armstrong, Jane Staunton, Lewis B. Silverman, Rob Pieters, Monique L. den Boer, Mark D. Minden, Stephen E. Sallan, Eric S. Lander, Todd R. Golub, Stanley J. Korsmeyer - Nature Genetics 2001 cited by 1,719

  3. Pretreatment Mitochondrial Priming Correlates with Clinical Response to Cytotoxic Chemotherapy

    Authors: Tríona Ní Chonghaile, Kristopher A. Sarosiek, Thanh-Trang T. Vo, Jeremy Ryan, Anupama Tammareddi, Victoria Del Gaizo Moore, Jing Deng, Kenneth C. Anderson, Paul G. Richardson, Yu‐Tzu Tai, Constantine S. Mitsiades, Ursula A. Matulonis, Ronny Drapkin, Richard M. Stone, Daniel J. DeAngelo, David J. McConkey, Stephen E. Sallan, Lewis B. Silverman, Michelle S. Hirsch, Daniel R. Carrasco, Anthony Letai - Science 2011 cited by 595

  4. Long-term Cardiovascular Toxicity in Children, Adolescents, and Young Adults Who Receive Cancer Therapy: Pathophysiology, Course, Monitoring, Management, Prevention, and Research Directions

    Authors: Steven E. Lipshultz, M. Jacob Adams, Steven D. Colan, Louis S. Constine, Eugene H. Herman, Daphne T. Hsu, Melissa M. Hudson, Leontien C.M. Kremer, David C. Landy, Tracie L. Miller, Kevin C. Oeffinger, David N. Rosenthal, Craig Sable, Stephen E. Sallan, Gautam K. Singh, Julia Steinberger, Thomas R. Cochran, James D. Wilkinson - Circulation 2013 cited by 614

  5. Maturation Stage of T-cell Acute Lymphoblastic Leukemia Determines BCL-2 versus BCL-XL Dependence and Sensitivity to ABT-199

    Authors: Tríona Ní Chonghaile, Justine E. Roderick, Cian Glenfield, Jeremy Ryan, Stephen E. Sallan, Lewis B. Silverman, Mignon L. Loh, Stephen P. Hunger, Brent L. Wood, Daniel J. DeAngelo, Richard M. Stone, Marian H. Harris, Alejandro Gutiérrez, Michelle A. Kelliher, Anthony Letai - Cancer Discovery 2014 cited by 274

  6. Long-term outcome of a pediatric-inspired regimen used for adults aged 18–50 years with newly diagnosed acute lymphoblastic leukemia

    Authors: Daniel J. DeAngelo, Kristen E. Stevenson, Suzanne E. Dahlberg, Lewis B. Silverman, Stephen Couban, Jeffrey G. Supko, Philip C. Amrein, Karen K. Ballen, M.D. Seftel, A. Robert Turner, Brian Leber, K Howson-Jan, Kara M. Kelly, Sandra Cohen, J. H. Matthews, Lynne Savoie, Martha Wadleigh, L. Andres Sirulnik, Ilene Galinsky, Donna Neuberg, Stephen E. Sallan, Richard M. Stone - Leukemia 2014 cited by 324

  7. Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial

    Authors: Steven E. Lipshultz, Rebecca E. Scully, Stuart R. Lipsitz, Stephen E. Sallan, Lewis B. Silverman, Tracie L. Miller, Elly Barry, Barbara L. Asselin, Uma H. Athale, Luis A. Clavell, Eric Larsen, Albert Moghrabi, Yvan Samson, Bruno Michon, Marshall A. Schorin, Harvey J. Cohen, Donna Neuberg, E. John Orav, Steven D. Colan - The Lancet Oncology 2010 cited by 447

  8. An Anatomical Site and Genetic-Based Prognostic Model for Patients With Nuclear Protein in Testis (NUT) Midline Carcinoma: Analysis of 124 Patients

    Authors: Nicole G. Chau, Clement Ma, Kristina Danga, Hasan Al‐Sayegh, Valentina Nardi, Ryan Barrette, Christopher S. Lathan, Steven G. DuBois, Robert I. Haddad, Geoffrey I. Shapiro, Stephen E. Sallan, Arindam Dhar, Jeanenne J. Nelson, Christopher A. French - JNCI Cancer Spectrum 2019 cited by 225

  9. Activity of the Type II JAK2 Inhibitor CHZ868 in B Cell Acute Lymphoblastic Leukemia

    Authors: Shuo-Chieh Wu, Loretta S. Li, Nadja Kopp, Joan Montero, Bjoern Chapuy, Akinori Yoda, Amanda L. Christie, Huiyun Liu, Alexandra Christodoulou, Diederik van Bodegom, Jordy Van Der Zwet, Jacob V. Layer, Trevor Tivey, Andrew A. Lane, Jeremy Ryan, Samuel Y. Ng, Daniel J. DeAngelo, Richard M. Stone, David P. Steensma, Martha Wadleigh, Marian H. Harris, Emeline Mandon, Nicolas Ebel, Rita Andraos, Vincent Romanet, Arno Dölemeyer, Dario Sterker, Michael Zender, Scott J. Rodig, Masato Murakami, Francesco Hofmann, Frank C. Kuo, Michael J. Eck, Lewis B. Silverman, Stephen E. Sallan, Anthony Letai, Fabienne Baffert, Eric Vangrevelinghe, Thomas Radimerski, Christoph Gaul, David M. Weinstock - Cancer Cell 2015 cited by 123

  10. Female Sex and Higher Drug Dose as Risk Factors for Late Cardiotoxic Effects of Doxorubicin Therapy for Childhood Cancer

    Authors: Steven E. Lipshultz, Stuart R. Lipsitz, Suzanne M. Mone, Allen M. Goorin, Stephen E. Sallan, Stephen P. Sanders, E. John Orav, Richard D. Gelber, Steven D. Colan - New England Journal of Medicine 1995 cited by 810

  11. Clinicopathologic Features and Long-term Outcomes of NUT Midline Carcinoma

    Authors: Daniel E. Bauer, Chelsey M. Mitchell, Kelly M. Strait, Christopher S. Lathan, Edward B. Stelow, Sonja Lüer, Somala Muhammed, Andrew G. Evans, Lynette M. Sholl, Juan Rosaí, Eugenia Giraldi, Richard Oakley, Carlos Rodríguez‐Galindo, Wendy B. London, Stephen E. Sallan, James E. Bradner, Christopher A. French - Clinical Cancer Research 2012 cited by 409

  12. Refining risk classification in childhood B acute lymphoblastic leukemia: results of DFCI ALL Consortium Protocol 05-001

    Authors: Lynda M. Vrooman, Traci M. Blonquist, Marian H. Harris, Kristen E. Stevenson, Andrew E. Place, Sarah K. Hunt, Jane E. O’Brien, Barbara L. Asselin, Uma H. Athale, Luis A. Clavell, Peter D. Cole, Kara M. Kelly, Caroline Laverdière, Jean‐Marie Leclerc, Bruno Michon, Marshall A. Schorin, Maria Luisa Sulis, Jennifer Welch, Donna Neuberg, Stephen E. Sallan, Lewis B. Silverman - Blood Advances 2018 cited by 115

  13. Postinduction Dexamethasone and Individualized Dosing of Escherichia Coli L-Asparaginase Each Improve Outcome of Children and Adolescents With Newly Diagnosed Acute Lymphoblastic Leukemia: Results From a Randomized Study—Dana-Farber Cancer Institute ALL Consortium Protocol 00-01

    Authors: Lynda M. Vrooman, Kristen E. Stevenson, Jeffrey G. Supko, Jane O’Brien, Suzanne E. Dahlberg, Barbara L. Asselin, Uma H. Athale, Luis A. Clavell, Kara M. Kelly, Jeffery L. Kutok, Caroline Laverdière, Steven E. Lipshultz, Bruno Michon, Marshall A. Schorin, Mary V. Relling, Harvey J. Cohen, Donna Neuberg, Stephen E. Sallan, Lewis B. Silverman - Journal of Clinical Oncology 2013 cited by 315

  14. Chronic Progressive Cardiac Dysfunction Years After Doxorubicin Therapy for Childhood Acute Lymphoblastic Leukemia

    Authors: Steven E. Lipshultz, Stuart R. Lipsitz, Stephen E. Sallan, Virginia Dalton, Suzanne M. Mone, Richard D. Gelber, Steven D. Colan - Journal of Clinical Oncology 2005 cited by 736

  15. The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice

    Authors: Elizabeth C. Townsend, Mark A. Murakami, Alexandra Christodoulou, Amanda L. Christie, Johannes Köster, Tiffany DeSouza, Elizabeth A. Morgan, Scott P. Kallgren, Huiyun Liu, Shuo-Chieh Wu, Olivia D. Plana, Joan Montero, Kristen E. Stevenson, Prakash K. Rao, Raga Vadhi, Michael Andreeff, Philippe Armand, Karen K. Ballen, Patrizia Barzaghi-Rinaudo, Sarah Cahill, Rachael A. Clark, Vesselina G. Cooke, Matthew S. Davids, Daniel J. DeAngelo, David M. Dorfman, Hilary Eaton, Benjamin L. Ebert, Julia Etchin, Brant Firestone, David C. Fisher, Arnold S. Freedman, Ilene Galinsky, Hui Gao, Jacqueline S. Garcia, Francine Garnache‐Ottou, Timothy A. Graubert, Alejandro Gutiérrez, Ensar Halilovic, Marian H. Harris, Zachary T. Herbert, Steven M. Horwitz, Giorgio Inghirami, Andrew M. Intlekofer, Moriko Ito, Shai Izraeli, Eric D. Jacobsen, Caron A. Jacobson, Sébastien Jeay, Irmela Jeremias, Michelle A. Kelliher, Raphael Koch, Marina Konopleva, Nadja Kopp, Steven M. Kornblau, Andrew L. Kung, Thomas S. Kupper, Nicole R. LeBoeuf, Ann S. LaCasce, Emma Lees, Loretta S. Li, A. Thomas Look, Masato Murakami, Markus Müschen, Donna Neuberg, Samuel Y. Ng, Oreofe O. Odejide, Stuart H. Orkin, Rachel R. Paquette, Andrew E. Place, Justine E. Roderick, Jeremy Ryan, Stephen E. Sallan, Brent Shoji, Lewis B. Silverman, Robert J. Soiffer, David P. Steensma, Kimberly Stegmaier, Richard M. Stone, Jérôme Tamburini, Aaron R. Thorner, Paul Van Hummelen, Martha Wadleigh, Marion Wiesmann, Andrew P. Weng, Jens Wuerthner, David A. Williams, Bruce M. Wollison, Andrew A. Lane, Anthony Letai, Monica M. Bertagnolli, Jerome Ritz, Myles Brown, Henry W. Long, Jon C. Aster, Margaret A. Shipp, James D. Griffin, David M. Weinstock - Cancer Cell 2016 cited by 304

  16. Intravenous pegylated asparaginase versus intramuscular native Escherichia coli l-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial

    Authors: Andrew E. Place, Kristen E. Stevenson, Lynda M. Vrooman, Marian H. Harris, Sarah K. Hunt, Jane E. O’Brien, Jeffrey G. Supko, Barbara L. Asselin, Uma H. Athale, Luis A. Clavell, Peter D. Cole, Kara M. Kelly, Caroline Laverdière, Jean-Marie Leclerc, Bruno Michon, Marshall A. Schorin, Jennifer Welch, Steven E. Lipshultz, Jeffery L. Kutok, Traci M. Blonquist, Donna Neuberg, Stephen E. Sallan, Lewis B. Silverman - The Lancet Oncology 2015 cited by 240

  17. Twenty-five–year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study

    Authors: Rajen Mody, Suwen Li, Douglas C. Dover, Stephen E. Sallan, Wendy M. Leisenring, Kevin C. Oeffinger, Yutaka Yasui, Leslie L. Robison, Joseph P. Neglia - Blood 2008 cited by 389

  18. Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance

    Authors: Guo Wei, David Twomey, Justin Lamb, Krysta Schlis, Jyoti Agarwal, Ronald W. Stam, Joseph T. Opferman, Stephen E. Sallan, Monique L. den Boer, Rob Pieters, Todd R. Golub, Scott A. Armstrong - Cancer Cell 2006 cited by 512

  19. The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemia

    Authors: Alejandro Gutiérrez, Alex Kentsis, Takaomi Sanda, Linda Holmfeldt, Shann-Ching Chen, Jianhua Zhang, Alexei Protopopov, Lynda Chin, Suzanne E. Dahlberg, Donna Neuberg, Lewis B. Silverman, Stuart S. Winter, Stephen P. Hunger, Stephen E. Sallan, Shan Zha, Frederick W. Alt, James R. Downing, Charles G. Mullighan, A. Thomas Look - Blood 2011 cited by 189

  20. Effect of BMI on toxicities and survival among adolescents and young adults treated on DFCI Consortium ALL trials

    Authors: Shai Shimony, Yael Flamand, Yannis K. Valtis, Andrew E. Place, Lewis B. Silverman, Lynda M. Vrooman, Andrew M. Brunner, Stephen E. Sallan, Richard M. Stone, Martha Wadleigh, Donna Neuberg, Daniel J. DeAngelo, Marlise R. Luskin - Blood Advances 2023 cited by 30

  21. The Effect of Dexrazoxane on Myocardial Injury in Doxorubicin-Treated Children with Acute Lymphoblastic Leukemia

    Authors: Steven E. Lipshultz, Nader Rifai, Virginia Dalton, Donna E. Levy, Lewis B. Silverman, Stuart R. Lipsitz, Steven D. Colan, Barbara L. Asselin, Ronald D. Barr, Luis A. Clavell, Craig A. Hurwitz, Albert Moghrabi, Yvan Samson, Marshall A. Schorin, Richard D. Gelber, Stephen E. Sallan - New England Journal of Medicine 2004 cited by 620

  22. Long-Term Enalapril Therapy for Left Ventricular Dysfunction in Doxorubicin-Treated Survivors of Childhood Cancer

    Authors: Steven E. Lipshultz, Stuart R. Lipsitz, Stephen E. Sallan, Valeriano C. Simbre, Seema Shaikh, Suzanne M. Mone, Richard D. Gelber, Steven D. Colan - Journal of Clinical Oncology 2002 cited by 305

  23. c-Myc inhibition prevents leukemia initiation in mice and impairs the growth of relapsed and induction failure pediatric T-ALL cells

    Authors: Justine E. Roderick, Jessica Tesell, Leonard D. Shultz, Michael A. Brehm, Dale L. Greiner, Marian H. Harris, Lewis B. Silverman, Stephen E. Sallan, Alejandro Gutiérrez, A. Thomas Look, Jun Qi, James E. Bradner, Michelle A. Kelliher - Blood 2014 cited by 157

  24. BCL-2 dependence and ABT-737 sensitivity in acute lymphoblastic leukemia

    Authors: Victoria Del Gaizo Moore, Krysta Schlis, Stephen E. Sallan, Scott A. Armstrong, Anthony Letai - Blood 2007 cited by 223